Latest Breaking News On - நுஸ்ரத் சங்கமித்திர - Page 1 : comparemela.com

Share this article Share this article PUNE, India and CORK, Ireland, June 10, 2021 /PRNewswire/ CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV. The funding round will accelerate validation of CyGenica s proprietary technology, which enables safe, targeted and affordable intercellular drug delivery. The current investment seed round was led by venture capital investor SOSV. Other investors participating in the round included the VOYAGER Health-Tech fund, David Rowan, founder of Voyagers.io and angel investors Sharaf Yamani and Sami Mikati. CyGenica intends to utilize the investment to accelerate the development of its disruptive drug delivery technology, establish as a key partner of biopharmaceutical companies in the advancement of cutting-edge therapeutics for cancer and rare diseases to improve patient s health and quality of life.

Sharaf yamaniSami mikatiPrnewswire cygenicaBill liaoDavid rowanNusrat sanghamitraTech fundCygenica ltdGenica ltdர சி து லியாவோடேவிட் ரோவன்நுஸ்ரத் சங்கமித்திரதொழில்நுட்பம் நிதி